TSXV/MDX (TSXV/MDX)

TSX Venture Exchange: TSXV/MDX · CAD

CA$0.05

+0.00 (0.0%)· Recorded snapshot

Market cap	14.8M
Revenue (ttm)	569.8K
Net income (ttm)	-6.2M
EPS (ttm)	-CA$0.02
Shares out	327.9M
Volume	137,300
Beta	1.76

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 569.8K
Net income (ttm): -6.2M
EPS (ttm): -CA$0.02
Market cap: 14.8M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSXV/MDX indicators

Market & fundamental data

Available fields

163

Groups with data

Currency

CAD

Showing 163 of 163 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-27
Enterprise value	CAD 23.4M
Exchange	TSX Venture Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1999
Industry	Medical Devices
Is primary listing	Yes
ISIN number	CA5850901037
Last earnings date	2025-11-27
Last refreshed	2026-10-28
Market cap	CAD 14.8M
Next earnings date	2026-11-27
Price	CAD 0.05
Price currency	CAD
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-28
Symbol	tsxv/MDX
Website	https://www.medxhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-43.04%
EV/Sales	41.12x
FCF / EV yield	-16.15%
FCF yield	-25.64%
P/S ratio	25.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-2.37%
Operating margin	-750.46%
Pretax margin	-1,086.06%
ROA	-361.91%
ROA (5Y)	-302.58%
ROCE	47.39%
SBC / revenue	97.27%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Gross profit growth (Q)	149.41%
Revenue growth	19.14%
Revenue growth (Q)	33.74%
Revenue growth (QoQ)	-33.4%
Revenue growth 10Y	-4.51%
Revenue growth 3Y	-0.68%
Revenue growth 5Y	-1.71%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -2,103
Depreciation and amortization	CAD -18,659
EBIT	CAD -4.3M
EBITDA	CAD -4.3M
EPS	CAD -0.02
FCF per share	CAD -0.01
Financing cash flow	CAD 3.7M
Free cash flow	CAD -3.8M
Free cash flow minus SBC	CAD -4.3M
Gross profit	CAD -13,478
Investing cash flow	CAD -2,103
Net borrowing	CAD 3.4M
Net cash flow	CAD -106,944
Net income	CAD -6.2M
Operating cash flow minus SBC	CAD -4.3M
Operating income	CAD -4.3M
Revenue	CAD 569,792
Stock-based compensation	CAD 554,261

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-233.17
Book value per share	CAD -0.03
Interest coverage	-2.56
Long-term assets	CAD 261,544
Long-term liabilities	CAD 1.7M
Net cash (debt)	CAD -8.7M
Net cash / market cap	-58.77%
Piotroski F-Score	2
Property, plant and equipment	CAD 261,544
Shareholders' equity	CAD -10.7M
Tangible book value	CAD -10.7M
Tangible book value per share	CAD -0.03
Total assets	CAD 485,655
Total cash	CAD 19,592
Total debt	CAD 8.7M
Total liabilities	CAD 11.2M
WACC	14.4%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.77
Current assets	CAD 224,111
Current liabilities	CAD 9.5M
Current ratio	0.02
Inventory turnover	2.14
Net working capital	CAD -2.3M
Quick ratio	0.01
Working capital	CAD -9.3M
Working capital turnover	-0.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-15.88%
Shareholder yield	-15.88%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-75%
10Y return CAGR	-12.95%
10Y total return	-75%
150-day SMA	CAD 0.05
15Y price change	12.5%
15Y return CAGR	0.79%
15Y total return	12.5%
1D price change	0%
1M price change	-10%
1M total return	-10%
1Y price change	-30.77%
1Y return CAGR	-30.79%
1Y total return	-30.77%
20-day SMA	CAD 0.05
200-day SMA	CAD 0.05
3M price change	-10%
3M total return	-10%
3Y price change	-35.71%
3Y return CAGR	-13.69%
3Y total return	-35.71%
50-day SMA	CAD 0.05
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.07
52-week high date	2026-02-02
52-week low	CAD 0.04
52-week low date	2026-05-13
5Y price change	-60.87%
5Y return CAGR	-17.11%
5Y total return	-60.87%
6M price change	-18.18%
6M total return	-18.18%
All-time high	CAD 0.65
All-time high date	2008-02-12
All-time low	CAD 0.02
All-time low date	2011-06-23
Average true range (ATR)	CAD 0.00
Average volume	60.7K
Beta (1Y)	0.05
Beta (2Y)	0.92
Beta (5Y)	1.76
Change from 52-week high	-30.77%
Change from 52-week low	12.5%
Change from all-time high	-93.08%
Change from all-time low	125%
Change from open	0%
Day's gap	0%
Dollar volume	CAD 6,179
High price	CAD 0.05
Low price	CAD 0.05
Monthly RSI	41.41
Open price	CAD 0.05
Previous close	CAD 0.05
Price vs 150-day SMA	-15.57%
Price vs 20-day SMA	-6.25%
Price vs 200-day SMA	-16.82%
Price vs 50-day SMA	-8.91%
Relative volume	2.26
RSI	43.26
Sharpe ratio	-0.13
Sharpe ratio (3Y)	0.48
Sharpe ratio (5Y)	0.29
Sortino ratio	-0.12
Sortino ratio (3Y)	0.79
Sortino ratio (5Y)	0.49
Volume	137.3K
Weekly RSI	39.33
YTD price change	-18.18%
YTD total return	-18.18%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	214.5M
Shares change (QoQ)	0%
Shares change (YoY)	15.88%
Shares held by insiders	6.92%
Shares outstanding	327.9M

Deeper analysis on TSXV/MDX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSXV/MDX report

Is a complete TSXV/MDX research report available?

No complete published report is available for tsxv/MDX (TSXV/MDX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSXV/MDX (TSXV/MDX)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/MDX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/MDX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSXV/MDX

Frequently asked questions